Autoimmune hepatitis following infliximab therapy for ankylosing spondylitis.
Med J Aust
; 187(9): 524-6, 2007 Nov 05.
Article
em En
| MEDLINE
| ID: mdl-17979620
ABSTRACT
Autoimmune hepatitis is a rare but increasingly recognised serious complication of treatment with the tumour necrosis factor-alpha (TNF-alpha) blocking agent, infliximab. This report adds to the small but growing number of articles describing this significant adverse effect. Baseline liver function should be routinely tested in all patients receiving anti-TNF-alpha agents, and periodic monitoring for the development of hepatitis is important.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Espondilite Anquilosante
/
Antirreumáticos
/
Hepatite Autoimune
/
Anticorpos Monoclonais
Limite:
Female
/
Humans
/
Middle aged
Idioma:
En
Ano de publicação:
2007
Tipo de documento:
Article